Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 1;179(5):576-83.
doi: 10.1093/aje/kwt299. Epub 2013 Dec 13.

Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study

Janet W Maynard, Mara A McAdams-DeMarco, Andrew Law, Linda Kao, Allan C Gelber, Josef Coresh, Alan N Baer

Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study

Janet W Maynard et al. Am J Epidemiol. .

Abstract

We examined racial differences in gout incidence among black and white participants in a longitudinal, population-based cohort and tested whether racial differences were explained by higher levels of serum urate. The Atherosclerosis Risk in Communities Study is a prospective, US population-based cohort study of middle-aged adults enrolled between 1987 and 1989 with ongoing annual follow-up through 2012. We estimated the adjusted hazard ratios and 95% confidence intervals of incident gout by race among 11,963 men and women using adjusted Cox proportional hazards models. The cohort was 23.6% black. The incidence rate of gout was 8.4 per 10,000 person-years (15.5/10,000 person-years for black men, 12.0/10,000 person-years for black women, 9.4/10,000 person-years for white men, and 5.0/10,000 person-years for white women; P < 0.001). Black participants had an increased risk of incident gout (for women, adjusted hazard ratio (HR) = 1.69, 95% confidence interval (CI): 1.29, 2.22; for men, adjusted HR = 1.92, 95% CI: 1.44, 2.56). Upon further adjustment for uric acid levels, there was modest attenuation of the association of race with incident gout (for women, adjusted HR = 1.62, 95% CI: 1.24, 2.22; for men, adjusted HR = 1.49, 95% CI: 1.11, 2.00) compared with white participants. In this US population-based cohort, black women and black men were at increased risk of developing gout during middle and older ages compared with whites, which appears, particularly in men, to be partly related to higher urate levels in middle-aged blacks.

Keywords: gout; inflammatory arthritis; race; uric acid.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart of Atherosclerosis Risk in Communities (ARIC) Study (United States, 1989–2012) participants showing the number of participants excluded for the analysis of race and gout.
Figure 2.
Figure 2.
Cumulative incidence of gout between 1987 and 2012 in the US-based Atherosclerosis Risk in Communities Study by race and sex. The cumulative incidence of gout by age was plotted using the Kaplan Meier method according to race and sex strata. The log-rank P value was less than 0.001.
Figure 3.
Figure 3.
Distribution of serum urate (in mg/dL) at cohort entry (1987–1989) in the US-based Atherosclerosis Risk in Communities Study by race and sex. The density of serum urate levels at cohort entry (baseline) and normal distribution were plotted by race and sex for A) white women; B) white men; C) black women; and D) black men.
See this image and copyright information in PMC

References

    1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–3141. - PubMed
    1. Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol. 2008;35(3):498–501. - PubMed
    1. Sundy JS, Hershfield MS. Uricase and other novel agents for the management of patients with treatment-failure gout. Curr Rheumatol Rep. 2007;9(3):258–264. - PubMed
    1. Halpern R, Mody RR, Fuldeore MJ, et al. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis. Curr Med Res Opin. 2009;25(7):1711–1719. - PubMed
    1. Halpern R, Fuldeore MJ, Mody RR, et al. The effect of serum urate on gout flares and their associated costs: an administrative claims analysis. J Clin Rheumatol. 2009;15(1):3–7. - PubMed

Publication types